These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27907988)

  • 41. De novo antimicrobial peptides with low mammalian cell toxicity.
    Javadpour MM; Juban MM; Lo WC; Bishop SM; Alberty JB; Cowell SM; Becker CL; McLaughlin ML
    J Med Chem; 1996 Aug; 39(16):3107-13. PubMed ID: 8759631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Temporin L: antimicrobial, haemolytic and cytotoxic activities, and effects on membrane permeabilization in lipid vesicles.
    Rinaldi AC; Mangoni ML; Rufo A; Luzi C; Barra D; Zhao H; Kinnunen PK; Bozzi A; Di Giulio A; Simmaco M
    Biochem J; 2002 Nov; 368(Pt 1):91-100. PubMed ID: 12133008
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Pro --> peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide.
    Zhu WL; Lan H; Park Y; Yang ST; Kim JI; Park IS; You HJ; Lee JS; Park YS; Kim Y; Hahm KS; Shin SY
    Biochemistry; 2006 Oct; 45(43):13007-17. PubMed ID: 17059217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Capping Agent-Dependent Toxicity and Antimicrobial Activity of Silver Nanoparticles: An
    Niska K; Knap N; Kędzia A; Jaskiewicz M; Kamysz W; Inkielewicz-Stepniak I
    Int J Med Sci; 2016; 13(10):772-782. PubMed ID: 27766027
    [No Abstract]   [Full Text] [Related]  

  • 45. Selective amino acid substitution reduces cytotoxicity of the antimicrobial peptide mastoparan.
    Irazazabal LN; Porto WF; Ribeiro SM; Casale S; Humblot V; Ladram A; Franco OL
    Biochim Biophys Acta; 2016 Nov; 1858(11):2699-2708. PubMed ID: 27423268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles.
    Abdel-Wahab BF; Awad GE; Badria FA
    Eur J Med Chem; 2011 May; 46(5):1505-11. PubMed ID: 21353349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the in vitro cytotoxicity of the antimicrobial peptide P34.
    Vaucher RA; da Motta Ade S; Brandelli A
    Cell Biol Int; 2010 Feb; 34(3):317-23. PubMed ID: 19947909
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of cyclodextrins on the proliferation of HaCaT keratinocytes in vitro.
    Hipler UC; Schönfelder U; Hipler C; Elsner P
    J Biomed Mater Res A; 2007 Oct; 83(1):70-9. PubMed ID: 17380497
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antimicrobial activity of magnolol and honokiol against periodontopathic microorganisms.
    Chang B; Lee Y; Ku Y; Bae K; Chung C
    Planta Med; 1998 May; 64(4):367-9. PubMed ID: 9619121
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro evaluation of natural and methylated cyclodextrins as buccal permeation enhancing system for omeprazole delivery.
    Figueiras A; Hombach J; Veiga F; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2009 Feb; 71(2):339-45. PubMed ID: 18796330
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides.
    Liu Y; Han F; Xie Y; Wang Y
    Biometals; 2011 Dec; 24(6):1069-78. PubMed ID: 21607695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipid selectivity in novel antimicrobial peptides: Implication on antimicrobial and hemolytic activity.
    Maturana P; Martinez M; Noguera ME; Santos NC; Disalvo EA; Semorile L; Maffia PC; Hollmann A
    Colloids Surf B Biointerfaces; 2017 May; 153():152-159. PubMed ID: 28236791
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects and mechanisms of the secondary structure on the antimicrobial activity and specificity of antimicrobial peptides.
    Mai XT; Huang J; Tan J; Huang Y; Chen Y
    J Pept Sci; 2015 Jul; 21(7):561-8. PubMed ID: 25826179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analogues of peptide SMAP-29 with comparable antimicrobial potency and reduced cytotoxicity.
    Dawson RM; Liu CQ
    Int J Antimicrob Agents; 2011 May; 37(5):432-7. PubMed ID: 21377841
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytotoxicity Assays as Predictors of the Safety and Efficacy of Antimicrobial Agents.
    Zipperer A; Kretschmer D
    Methods Mol Biol; 2017; 1520():107-118. PubMed ID: 27873248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design of perfectly symmetric Trp-rich peptides with potent and broad-spectrum antimicrobial activities.
    Yang ST; Shin SY; Hahm KS; Kim JI
    Int J Antimicrob Agents; 2006 Apr; 27(4):325-30. PubMed ID: 16563706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plectasin has antibacterial activity and no affect on cell viability or IL-8 production.
    Hara S; Mukae H; Sakamoto N; Ishimoto H; Amenomori M; Fujita H; Ishimatsu Y; Yanagihara K; Kohno S
    Biochem Biophys Res Commun; 2008 Oct; 374(4):709-13. PubMed ID: 18675251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antimicrobial effect of sophoraflavanone G isolated from Sophora flavescens against mutans streptococci.
    Kim CS; Park SN; Ahn SJ; Seo YW; Lee YJ; Lim YK; Freire MO; Cho E; Kook JK
    Anaerobe; 2013 Feb; 19():17-21. PubMed ID: 23178373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibacterial and antibiofilm activities of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) against periodontopathic bacteria.
    Sun M; Zhou Z; Dong J; Zhang J; Xia Y; Shu R
    Microb Pathog; 2016 Oct; 99():196-203. PubMed ID: 27565090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conjugation of Polyphosphoester and Antimicrobial Peptide for Enhanced Bactericidal Activity and Biocompatibility.
    Pranantyo D; Xu LQ; Kang ET; Mya MK; Chan-Park MB
    Biomacromolecules; 2016 Dec; 17(12):4037-4044. PubMed ID: 27936728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.